CMPS COMPASS Pathways Plc - American Depository Shares
$13.94
价格 · 八月 19, 2026
截至...的财报数据 八月 5, 2026
52周区间
$4–$15
87% of range
分析师评级
BUY
24 analysts
目标价
$24
+70% upside
P/E (TTM)
-4.5
ROE
-524.8%
净利润率
—
关于 COMPASS Pathways Plc - American Depository Shares 公司概况（来自维基百科）
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
阅读更多
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
CMPS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$13.94
市值
$1.34B
P/E (TTM)
-4.5
每股收益 (TTM)
$-3.08
营收 (TTM)
—
股息收益率
—
ROE
-524.8%
负债/权益
-0.6
52周区间
$4 – $15
CMPS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-3.08
2019-12-31
→
2025-12-31
自由现金流
—
2021-12-31
→
2024-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CMPS
同行中位数
P/E (TTM)
-4.5
66.9
P/B (市净率)
-25.3
3.7
EV / EBITDA (企业价值 / EBITDA)
-6.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CMPS
同行中位数
ROA
-135.8%
-23.9%
ROE
-524.8%
-27.7%
ROIC
836.7%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CMPS
同行中位数
Debt / Equity (负债/股东权益比率)
-0.6
4.4
Current Ratio (流动比率)
0.8
4.0
Quick Ratio (速动比率)
0.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CMPS
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CMPS
同行中位数
CMPS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
24 位分析师
- 强烈买入 8 33.3%
- 买入 14 58.3%
- 持有 2 8.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
16 位分析师 · 2026-08-16
中位数
$21.00
现在
$13.94
最低
$13.00
最高
$65.00
中位数目标
$21.00
+50.6%
平均目标
$23.75
+70.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.27%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.88 | $-0.41 | -1.5% |
| 2026年3月31日 | $0.71 | $-0.39 | 1.1% |
| 2025年12月31日 | $-1.00 | $-0.40 | -0.60% |
| 2025年9月30日 | $-1.44 | $-0.40 | -1.0% |
| 2025年6月30日 | $-0.41 | $-0.44 | 0.03% |
| 2025年3月31日 | $-0.38 | $-0.48 | 0.10% |
| 2024年12月31日 | $-0.63 | $-0.64 | 0.01% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
现金流 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
估值 (TTM) 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
盈利能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-288M | $-155M | $-118M | $-92M | $-72M |
| 稀释后每股收益 (EPS) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | -0.6 | 0.2 | — | — | — |
| 流动比率 | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| 速动比率 | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | $-119M | $-97M | $-106M | $-68M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 250 家申报者 · $1.3B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 66 (+6 与上一季度对比) | 30 (+7 与上一季度对比) | 77 (+3 与上一季度对比) | 53 (+26 与上一季度对比) | -2.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Deep Track Capital, LP | $172085168 | 12161496 | 13.73% | 股份 |
| RTW INVESTMENTS, LP | $151418782 | 10700974 | 12.08% | 股份 |
| BIT Capital GmbH | $89835478 | 6348797 | 7.17% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $70750000 | 5000000 | 5.65% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $63257363 | 4470485 | 5.05% | 股份 |
| ARK Investment Management LLC | $48845310 | 3451965 | 3.90% | 股份 |
| Point72 Asset Management, L.P. | $37085424 | 2620878 | 2.96% | 股份 |
| Logos Global Management LP | $31837500 | 2250000 | 2.54% | 股份 |
| Eagle Health Investments LP | $29155042 | 2060427 | 2.33% | 股份 |
| DAFNA Capital Management LLC | $28469121 | 2011952 | 2.27% | 股份 |
| BANK OF AMERICA CORP /DE/ | $28339691 | 2002805 | 2.26% | 股份 |
| Caption Management, LLC | $27544390 | 1946600 | 2.20% | 买入期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26855285 | 1897900 | 2.14% | 买入期权 |
| NEXTBio Capital Management LP | $25126990 | 1775759 | 2.00% | 股份 |
| MARSHALL WACE, LLP | $20935350 | 1479530 | 1.67% | 股份 |
| Aisling Capital Management LP | $20267554 | 1432336 | 1.62% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $20261229 | 1431889 | 1.62% | 股份 |
| Candriam S.C.A. | $18013686 | 1274278 | 1.44% | 股份 |
| Woodline Partners LP | $15366957 | 1086004 | 1.23% | 股份 |
| Jefferies Financial Group Inc. | $14070661 | 994393 | 1.12% | 股份 |
| Trexquant Investment LP | $12171236 | 860158 | 0.97% | 股份 |
| Kalehua Capital Management LLC | $11598642 | 819692 | 0.93% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $10909466 | 770987 | 0.87% | 股份 |
| Caption Management, LLC | $10699041 | 756116 | 0.85% | 股份 |
| Eversept Partners, LP | $9520474 | 672825 | 0.76% | 股份 |
| Propel Bio Management, LLC | $8109167 | 573086 | 0.65% | 股份 |
| Creek Drive Management Group LLC | $8093800 | 572000 | 0.65% | 股份 |
| Occam Crest Management LP | $7739000 | 710000 | 0.62% | 股份 |
| CITADEL ADVISORS LLC | $7567420 | 534800 | 0.60% | 买入期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7140090 | 504600 | 0.57% | 卖出期权 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7122855 | 503382 | 0.57% | 股份 |
| JANE STREET GROUP, LLC | $7075821 | 500058 | 0.56% | 股份 |
| Qube Research & Technologies Ltd | $7070415 | 499676 | 0.56% | 股份 |
| Walleye Capital LLC | $6893385 | 487165 | 0.55% | 股份 |
| Ensign Peak Advisors, Inc | $6716340 | 474653 | 0.54% | 股份 |
| Blue Owl Capital Holdings LP | $6367500 | 450000 | 0.51% | 股份 |
| AdvisorShares Investments LLC | $5962060 | 421347 | 0.48% | 股份 |
| CITADEL ADVISORS LLC | $5952679 | 420684 | 0.47% | 股份 |
| TWO SIGMA ADVISERS, LP | $5909850 | 856500 | 0.47% | 股份 |
| GOLDMAN SACHS GROUP INC | $5540956 | 391587 | 0.44% | 股份 |
| HighVista Strategies LLC | $5251349 | 371120 | 0.42% | 股份 |
| Legal & General Group Plc | $4700154 | 332206 | 0.38% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $4573407 | 323209 | 0.36% | 股份 |
| Amova Asset Management Americas, Inc. | $4517334 | 319472 | 0.36% | 股份 |
| Squadron Capital Management LLC | $4315750 | 305000 | 0.34% | 买入期权 |
| Affinity Asset Advisors, LLC | $4261739 | 301183 | 0.34% | 股份 |
| SEVEN GRAND MANAGERS, LLC | $4245000 | 300000 | 0.34% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4245000 | 300000 | 0.34% | 股份 |
| Squadron Capital Management LLC | $4245000 | 300000 | 0.34% | 股份 |
| AMERIPRISE FINANCIAL INC | $4081271 | 288429 | 0.33% | 股份 |
| JANE STREET GROUP, LLC | $4079445 | 288300 | 0.33% | 买入期权 |
| STEMPOINT CAPITAL LP | $4029481 | 284769 | 0.32% | 股份 |
| TORONTO DOMINION BANK | $3930233 | 277755 | 0.31% | 股份 |
| ROYCE & ASSOCIATES LP | $3778885 | 267059 | 0.30% | 股份 |
| PFM Health Sciences, LP | $3503384 | 247589 | 0.28% | 股份 |
| D. E. Shaw & Co., Inc. | $3408367 | 240874 | 0.27% | 股份 |
| Brown University | $3030930 | 214200 | 0.24% | 股份 |
| MORGAN STANLEY | $2973693 | 210155 | 0.24% | 股份 |
| Caption Management, LLC | $2950275 | 208500 | 0.24% | 卖出期权 |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2913938 | 205932 | 0.23% | 股份 |
| CITADEL ADVISORS LLC | $2695575 | 190500 | 0.22% | 卖出期权 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2481528 | 175373 | 0.20% | 股份 |
| Engineers Gate Manager LP | $2432343 | 171897 | 0.19% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $2378474 | 168090 | 0.19% | 股份 |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2122500 | 150000 | 0.17% | 股份 |
| Squarepoint Ops LLC | $1962195 | 138671 | 0.16% | 股份 |
| Balyasny Asset Management L.P. | $1959492 | 138480 | 0.16% | 股份 |
| ALPS ADVISORS INC | $1930937 | 136462 | 0.15% | 股份 |
| Founders Fund VII Management, LLC | $1924272 | 278880 | 0.15% | 股份 |
| K2 PRINCIPAL FUND, L.P. | $1911665 | 135100 | 0.15% | 股份 |
| WELLS FARGO & COMPANY/MN | $1897246 | 134081 | 0.15% | 股份 |
| CenterBook Partners LP | $1777155 | 125594 | 0.14% | 股份 |
| Creek Drive Management Group LLC | $1698000 | 120000 | 0.14% | 买入期权 |
| BANK OF MONTREAL /CAN/ | $1686991 | 119222 | 0.13% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $1639118 | 115839 | 0.13% | 股份 |
| Palo Alto Investors LP | $1635966 | 115616 | 0.13% | 股份 |
| Simplify Asset Management Inc. | $1617076 | 114281 | 0.13% | 股份 |
| LPL Financial LLC | $1550387 | 109568 | 0.12% | 股份 |
| GROUP ONE TRADING LLC | $1390917 | 98298 | 0.11% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $1341448 | 94802 | 0.11% | 股份 |
| CreativeOne Wealth, LLC | $1336312 | 94439 | 0.11% | 股份 |
| STABLEFORD CAPITAL II LLC | $1300003 | 91873 | 0.10% | 股份 |
| STATE STREET CORP | $1150098 | 81279 | 0.09% | 股份 |
| Lion Point Capital, LP | $1132000 | 80000 | 0.09% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $1063896 | 75187 | 0.08% | 股份 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1016635 | 71847 | 0.08% | 股份 |
| DLD Asset Management, LP | $990500 | 70000 | 0.08% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941852 | 66562 | 0.08% | 股份 |
| Aquatic Capital Management LLC | $922297 | 65180 | 0.07% | 股份 |
| JANE STREET GROUP, LLC | $915505 | 64700 | 0.07% | 卖出期权 |
| Dorsey Wright & Associates | $883653 | 62449 | 0.07% | 股份 |
| Campbell & CO Investment Adviser LLC | $874696 | 61816 | 0.07% | 股份 |
| STIFEL FINANCIAL CORP | $855639 | 60469 | 0.07% | 股份 |
| Intellectus Partners, LLC | $841925 | 59500 | 0.07% | 股份 |
| DCF Advisers, LLC | $767638 | 54250 | 0.06% | 股份 |
| CIBC WORLD MARKET INC. | $737357 | 52110 | 0.06% | 股份 |
| NATIONAL BANK OF CANADA /FI/ | $731420 | 51727 | 0.06% | 股份 |
| FLAX POND CAPITAL, LLC | $728951 | 51516 | 0.06% | 股份 |
| EXCHANGE TRADED CONCEPTS, LLC | $708943 | 50102 | 0.06% | 股份 |
| PEAK6 LLC | $707500 | 50000 | 0.06% | 买入期权 |
公司内部人士 9 位内幕人士 · 0 位高管 · 0 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 2026年8月3日 F | 361028 | 0 | 0 | $0 |
| Robert Mcquade | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| David Y Norton | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Gino Santini | — | 2026年5月27日 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 2026年5月27日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 2026年2月17日 | 4.96% | 修订 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 6 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2.43% | 3316076 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.99% | 40950 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.06% | 3487 NS | 2026年5月31日 | N-PORT |
| APIE · Trust for Professional Managers | 0.03% | 21455 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |